Oman Pharmaceuticals & Healthcare Q1 2021
Oman's economy will contract in 2020 amid the effects of the sharp drop in oil prices and the Covid-19 pandemic. Thiswill mean further price revisions and continued tight scrutiny of the pharmaceutical industry to ensure the government's healthspending yields the best value for money possible, while still providing a good service across the country. A high burden of chronicdiseases and alignment of regulations with the rest of the Gulf Cooperation Council countries will provide a little alleviation from thedrawback of Oman's small market size while the country is also moving ahead with a number of agreements with internationalpartners to help develop its health sector. Meanwhile, the planned investment of OMR497mn into a new Medical City in Muscat, aspart of the government's economic expansion plan, should help encourage an increase in private sector investment into the sector.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook